Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States
详细信息 查看全文
- 作者：Alexander Melamed ; MD ; MPHa ; amelamed@partners.org" class="auth_mail" title="E-mail the corresponding author ; Emily M. Hinchcliff ; MDa ; Joel T. Clemmer ; MAa ; Amy J. Bregar ; MD ; MSa ; Shitanshu Uppal ; MDb ; Ian Bostock ; MDc ; John O. Schorge ; MDa ; Marcela G. del Carmen ; MD ; MPHa ; J. Alejandro Rauh-Hain ; MDa
- 关键词：Neoadjuvant chemotherapy ; Advanced ovarian cancer ; Temporal trends
- 刊名：Gynecologic Oncology
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：143
- 期：2
- 页码：236-240
- 全文大小：414 K
文摘
- •
Treatment of advanced ovarian cancer with neoadjuvant chemotherapy became more frequent between 2004 and 2013
- •
Utilization of neoadjuvant chemotherapy began to increase in 2007
- •
Neoadjuvant chemotherapy was adopted most rapidly among elderly women, and those with stage IV ovarian cancer